Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| ProNAi Therapeutics Inc | 2 433 577 | déclaré | 21 juil. 2015 | tx 8+2 438 270−2 109 299 |
| VYNE Therapeutics Inc. | 486 695 | déclaré | 29 janv. 2018 | tx 10+4 011 236−10 026 934 |
| BIOFORM MEDICAL INC | 412 588 | déclaré | 09 nov. 2007 | tx 15+1 851 542−1 851 542 |
| Biohaven Pharmaceutical Holding Co Ltd. | 18 000 | déclaré | 01 mai 2018 | tx 5+2 067 545−1 506 818 |
| Biodel Inc | 10 000 | déclaré | 28 févr. 2008 | tx 4+1 088 933−1 210 933 |
| KalVista Pharmaceuticals, Inc. | 10 000 | déclaré | 26 sept. 2023 | tx 52+9 788 283−6 420 126 |
| Aclaris Therapeutics, Inc. | 6 632 | déclaré | 29 juin 2016 | tx 7+3 908 175−11 846 087 |
| SOLENO THERAPEUTICS INC | 0 | déclaré | 18 nov. 2014 | tx 47+5 687 041−11 818 669,85 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 26 sept. 2023 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 10 000 | 0.00 USD | deriv |
| 11 sept. 2023 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6 000 | 6.71 USD | |
| 11 sept. 2023 | SALE | KalVista Pharmaceuticals, Inc. | 18 000 | 10.50 USD | |
| 11 sept. 2023 | EXERCISE | KalVista Pharmaceuticals, Inc. | 12 000 | 7.88 USD | |
| 11 sept. 2023 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6 000 | 0.00 USD | deriv |
| 11 sept. 2023 | EXERCISE | KalVista Pharmaceuticals, Inc. | 12 000 | 0.00 USD | deriv |
| 13 oct. 2022 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 10 000 | 0.00 USD | deriv |
| 30 sept. 2021 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 10 000 | 0.00 USD | deriv |
| 30 oct. 2020 | PURCHASE | KalVista Pharmaceuticals, Inc. | 47 431 | 17.34 USD | 1er après silence |
| 30 oct. 2020 | PURCHASE | KalVista Pharmaceuticals, Inc. | 68 255 | 17.17 USD | |
| 01 oct. 2020 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 7 000 | 0.00 USD | deriv |
| 02 oct. 2019 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 7 000 | 0.00 USD | deriv |
| 26 juil. 2019 | PURCHASE | KalVista Pharmaceuticals, Inc. | 4 558 | 16.83 USD | |
| 29 juil. 2019 | PURCHASE | KalVista Pharmaceuticals, Inc. | 24 730 | 17.13 USD | |
| 29 juil. 2019 | PURCHASE | KalVista Pharmaceuticals, Inc. | 5 137 | 17.13 USD | |
| 26 juil. 2019 | PURCHASE | KalVista Pharmaceuticals, Inc. | 21 942 | 16.83 USD | |
| 17 juil. 2019 | PURCHASE | KalVista Pharmaceuticals, Inc. | 1 060 | 16.97 USD | |
| 17 juil. 2019 | PURCHASE | KalVista Pharmaceuticals, Inc. | 220 | 16.93 USD | |
| 19 juil. 2019 | PURCHASE | KalVista Pharmaceuticals, Inc. | 49 680 | 17.84 USD | |
| 19 juil. 2019 | PURCHASE | KalVista Pharmaceuticals, Inc. | 10 320 | 17.68 USD | |
| 03 oct. 2018 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 7 000 | 0.00 USD | deriv |
| 10 sept. 2018 | PURCHASE | KalVista Pharmaceuticals, Inc. | 1 058 824 | 17.00 USD | |
| 01 mai 2018 | GRANT_AWARD | Biohaven Pharmaceutical Holding Co Ltd. | 18 000 | 0.00 USD | deriv |
| 14 mars 2018 | GRANT_AWARD | Biohaven Pharmaceutical Holding Co Ltd. | 72 727 | 27.50 USD | |
| 25 janv. 2018 | PURCHASE | VYNE Therapeutics Inc. | 35 686 | 17.00 USD |
2 achats déclarés après au moins 12 mois de silence — dernière occurrence le 30 oct. 2020.